FR2925331B1 - Utilisation d'un hydrolysat de feve en tant que principe actif activateur de la synthese des aquaporines - Google Patents

Utilisation d'un hydrolysat de feve en tant que principe actif activateur de la synthese des aquaporines

Info

Publication number
FR2925331B1
FR2925331B1 FR0708984A FR0708984A FR2925331B1 FR 2925331 B1 FR2925331 B1 FR 2925331B1 FR 0708984 A FR0708984 A FR 0708984A FR 0708984 A FR0708984 A FR 0708984A FR 2925331 B1 FR2925331 B1 FR 2925331B1
Authority
FR
France
Prior art keywords
hydrolysat
feve
active ingredient
aquaporin synthesis
activator active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0708984A
Other languages
English (en)
Other versions
FR2925331A1 (fr
Inventor
Farra Claude Dal
Nouha Domloge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vincience SA
Original Assignee
Vincience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vincience SA filed Critical Vincience SA
Priority to FR0708984A priority Critical patent/FR2925331B1/fr
Publication of FR2925331A1 publication Critical patent/FR2925331A1/fr
Application granted granted Critical
Publication of FR2925331B1 publication Critical patent/FR2925331B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
FR0708984A 2007-12-21 2007-12-21 Utilisation d'un hydrolysat de feve en tant que principe actif activateur de la synthese des aquaporines Expired - Fee Related FR2925331B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0708984A FR2925331B1 (fr) 2007-12-21 2007-12-21 Utilisation d'un hydrolysat de feve en tant que principe actif activateur de la synthese des aquaporines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0708984A FR2925331B1 (fr) 2007-12-21 2007-12-21 Utilisation d'un hydrolysat de feve en tant que principe actif activateur de la synthese des aquaporines

Publications (2)

Publication Number Publication Date
FR2925331A1 FR2925331A1 (fr) 2009-06-26
FR2925331B1 true FR2925331B1 (fr) 2010-04-09

Family

ID=39414976

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0708984A Expired - Fee Related FR2925331B1 (fr) 2007-12-21 2007-12-21 Utilisation d'un hydrolysat de feve en tant que principe actif activateur de la synthese des aquaporines

Country Status (1)

Country Link
FR (1) FR2925331B1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10072293B2 (en) 2011-03-31 2018-09-11 The Procter And Gamble Company Systems, models and methods for identifying and evaluating skin-active agents effective for treating dandruff/seborrheic dermatitis

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2963234B1 (fr) 2010-07-29 2020-07-17 Isp Investments Inc Utilisation d'une composition comprenant un extrait peptidique de feves pour stimuler la pousse des cheveux
ES2396815B1 (es) 2011-05-23 2014-01-20 Consejo Superior De Investigaciones Científicas (Csic) Procedimiento de obtención y usos de vesículas de membrana plasmática extraídas de plantas enriquecidas en proteínas transportadoras de membrana.
WO2013184908A2 (fr) 2012-06-06 2013-12-12 The Procter & Gamble Company Systèmes et procédés d'identification d'agents cosmétiques pour des compositions de soins de cheveux/cuir chevelu
US10405795B1 (en) 2013-03-15 2019-09-10 The Procter & Gamble Company Methods of classifying periorbital dyschromia and systems therefor
US20170296459A1 (en) * 2016-04-14 2017-10-19 The Procter & Gamble Company Method of improving the appearance of periorbital dyschromia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0925225A (ja) * 1995-05-09 1997-01-28 Sansho Seiyaku Co Ltd 皮膚外用剤およびその有効成分の製造方法
FR2838343B1 (fr) * 2002-04-12 2004-05-28 Oreal Composition cosmetique sous forme d'emulsion multiple comprenant un agent tenseur
FR2878438B1 (fr) * 2004-11-26 2009-07-03 Oreal Composition cosmetique comprenant un agent tenseur et une hydroxyalkyl uree

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10072293B2 (en) 2011-03-31 2018-09-11 The Procter And Gamble Company Systems, models and methods for identifying and evaluating skin-active agents effective for treating dandruff/seborrheic dermatitis

Also Published As

Publication number Publication date
FR2925331A1 (fr) 2009-06-26

Similar Documents

Publication Publication Date Title
FR2925326B1 (fr) Utilisation d'un hydrolysat de mais en tant que principe actif activateur de la synthese des aquaporines
FR2925332B1 (fr) Utilisation d'un hydrolysat d'epeautre en tant que principe actif activateur de la synthese des aquaporines
FR2925329B1 (fr) Utilisation d'un hydrolysat d'avoine en tant que principe actif activateur de la synthese des aquaporines
FR2925325B1 (fr) Utilisation d'un hydrolysat de colza en tant que principe actif activateur de la synthese des aquaporines
SV2009003376A (es) Derivados de aril isoxazolinas insecticidas
SV2010003472A (es) Compuestos de pirazol
ECSP12012174A (es) Derivados de n-(imidazopirimidin-7-il)-heteroarilamida y su uso como inhibidores de pde10a
FR2925330B1 (fr) Utilisation d'un hydrolysat de pomme de terre en tant que principe actif activateur de la synthese des aquaporines
CL2008002694A1 (es) Combinaciones de principios activos que contienen derivados de acido tetramico sustituido con espirocetal; uso de las combinaciones para combatir plagas animales.
UY33779A (es) ?2-(fenilamino)-1H-bencimidazol-5-carboxamidas novedosas?
DOP2012000314A (es) Compuestos, composiciones de tiocetato y metodos de uso
CR20110354A (es) Compuestos de amidina sustituidas para combatir plagas de animales
CR10662A (es) Compuestos de metilpiridopirimidinona
CO6430459A2 (es) Derivados de prolina como inhibidores de catepsina
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
FR2925331B1 (fr) Utilisation d'un hydrolysat de feve en tant que principe actif activateur de la synthese des aquaporines
ECSP088925A (es) Nitrilos espirocíclicos como inhibidores de proteasa
GT200600366A (es) Compuestos de imidazol sustituido como inhibidores de ksp
CR20110269A (es) Lactamas como inhibidores de beta secretasa
CO6480909A2 (es) Derivados de tiazolilpiperidina como fungicidas.
BRPI0813926A2 (pt) Utilização de uma substância, composição e métodos de triagem de princípios ativos que inibem a formação dos ages e de cuidado cosmético.
CL2012000077A1 (es) Combinaciones de principios activos que contienen al menos un compuesto derivado de triazol con un grupo sulfóxido quiral; uso de dicha combinación porque sirve para combatir parásitos animales y/u hongos fitopatógenos.
CO6741154A2 (es) Compuestos de triazolopiridina
FR2916633B1 (fr) Utilisation cosmetique d'un actif capable de stimuler l'expression de la tensine 1
CR20110680A (es) Sulfonamidas heterociclicas, usos y composiciones farmacéuticas de las mismas

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20150831